| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 05/10/2006 | EP1654255A1 Substituted indazolyl(indolyl)maleimide derivatives as kinase inhibitors |
| 05/10/2006 | EP1654252A2 Substituted quinolines serving as antimicrobial agents |
| 05/10/2006 | EP1654251A1 Chemical compounds |
| 05/10/2006 | EP1654250A1 Substituted pyridones and pyrimidinones with antiinflammatory properties |
| 05/10/2006 | EP1654249A1 Anthelmintic and insecticide pyrimidine derivatives |
| 05/10/2006 | EP1654238A1 2-aminopyrimidine and 2-aminopyridine-4-carbamates for use in the treatment of autoimmune diseases |
| 05/10/2006 | EP1654234A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 05/10/2006 | EP1654232A1 Sulfonyl substituted n-(biarylmethyl) aminocyclopropanecarboxamides |
| 05/10/2006 | EP1654229A1 Piperidine derivatives as ccr5 receptor modulators |
| 05/10/2006 | EP1654228A1 Tetrahydrocarbazole derivatives and their pharmaceutical use |
| 05/10/2006 | EP1653967A2 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia |
| 05/10/2006 | EP1653965A1 Quinazoline derivatives as inhibitors of vegf receptor tyrosine kinases |
| 05/10/2006 | EP1653961A1 Inhibitors of akt activity |
| 05/10/2006 | EP1653960A2 Melanin concentrating hormone receptor antagonist |
| 05/10/2006 | EP1653951A1 Benzimidazole derivatives as raf kinase inhibitors |
| 05/10/2006 | EP1536799B1 Novel 2-amino-4-oxoquinazolones as lxr nuclear receptor binding compounds with partial agonistic properties |
| 05/10/2006 | EP1370553B1 Rho-kinase inhibitors |
| 05/10/2006 | EP1358179B1 Synthesis method and intermediates of pyridin-2-yl-methylamine |
| 05/10/2006 | EP1282630B1 Process for Reducing the Molecular Weight of Polypropylene Using Hydroxylamine Esters |
| 05/10/2006 | EP1212296B9 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 05/10/2006 | EP1208186B1 Composition and method for bleaching a substrate |
| 05/10/2006 | EP1104403B1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 05/10/2006 | EP1049700B9 Chemokine receptor antagonists and methods of use therefor |
| 05/10/2006 | CN1771249A Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses. |
| 05/10/2006 | CN1771248A Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses. |
| 05/10/2006 | CN1771245A Novel crystals of fluorobenzamide derivative |
| 05/10/2006 | CN1771244A Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands |
| 05/10/2006 | CN1771237A Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses. |
| 05/10/2006 | CN1771228A Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof. |
| 05/10/2006 | CN1770980A Pyrazoles and methods of making and using the same |
| 05/10/2006 | CN1769283A Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 05/10/2006 | CN1769282A Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 05/10/2006 | CN1769274A Pyrazinone protease inhibitors |
| 05/10/2006 | CN1768745A Agents for improving excretory potency of urinary bladder |
| 05/10/2006 | CN1255419C Ligands and catalyst systems thereof for ethylene oligomerisation to produce linear alpha olefins |
| 05/10/2006 | CN1255401C Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists |
| 05/10/2006 | CN1255387C Pyrimidine derivatives useful as selective COX-2 inhibitors |
| 05/10/2006 | CN1255380C Pyrrolecarboxamides and pyrrolethioamides as fungicides |
| 05/09/2006 | US7041837 Heterocyclic compounds having hypolipidemic, hypocholesteremic activities process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 05/09/2006 | US7041828 Phenyl-substituted imidazopyridines |
| 05/09/2006 | US7041827 Phenyl-substituted imidazopyridines |
| 05/09/2006 | US7041693 Antiarthritic agents; osteoporosis; antitumor agents; antiulcer agents; antiinflammatory agents |
| 05/09/2006 | US7041691 E.g., 2-(2,6-Dichloro-4-nitro-phenylsulfanyl)-benzothiazole-5-carboxylic acid methyl ester; modulators of peroxisome proliferator-activated receptors (PPARs) to treat type 11 diabetes and obesity; hypertension, hyperlipidemia, hypercholesterolemia, and hyperlipoproteinemia; antiinflammatory agents |
| 05/09/2006 | US7041687 Indazole compounds useful as protein kinase inhibitors |
| 05/09/2006 | US7041686 Substituted imidazoles useful in the treatment of inflammatory diseases |
| 05/09/2006 | US7041684 4-[2-Hydroxy-3-([4-(5-carbamoyl-2-pyridyloxy)phenyl]-2-methylpropylamino)propoxy]carbazole and salts;treating obesity; antidiabetic agent for non-insulin dependent diabetes (Type II); |
| 05/09/2006 | US7041682 Antiemetics, antidepressants, anxiolytic agents, antitussive agents |
| 05/09/2006 | US7041681 Nitrogen heterocyclic compounds, e.g., 3-(2-oxo-2-phenyl-ethylcarbamoyl)-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester; treating pain and gastrointestinal disorders. |
| 05/09/2006 | US7041680 (R) and (S) isomers of substituted 2-(2,6-dioxopiperidin-3-yl) phthalimides and 1-oxoisoindolines and methods of using the same |
| 05/09/2006 | US7041679 Crystallization, filtration; neurokinins receptor antagonist |
| 05/09/2006 | US7041676 Compounds, compositions, and methods |
| 05/09/2006 | US7041672 Substituted aryl 1, 4-pyrazine derivatives |
| 05/09/2006 | US7041669 1,4-benzofused urea compounds useful in treating cytokine mediated diseases |
| 05/09/2006 | US7041668 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 05/09/2006 | US7041667 CCR5 modulators |
| 05/09/2006 | US7041664 e.g., (S)-N-(1-phenylpropyl)-2-(pyrrolidin-1-yl)-quinoline-4-carboxamide in a container with instructions for treating anxiety, depression, schizophrenia, obesity, chronic pulmonary obstructive disorder, or pain |
| 05/09/2006 | CA2418908C 1,4-dihydropyridines as bradykinin antagonists |
| 05/09/2006 | CA2262668C Inhibitors of cathepsin k |
| 05/09/2006 | CA2257646C Benzo[g]quinoline derivatives |
| 05/09/2006 | CA2238430C Pyrazole derivatives, method for preparing same, and pharmaceutical compositions containing said derivatives |
| 05/04/2006 | WO2006047504A1 Aromatic amides as inhibitors of c-fms kinase |
| 05/04/2006 | WO2006047256A1 Triazoles useful as inhibitors of protein kinases |
| 05/04/2006 | WO2006046914A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 05/04/2006 | WO2006046910A1 Novel use |
| 05/04/2006 | WO2006046778A1 3-carbamoyl-2-pyridone derivative |
| 05/04/2006 | WO2006046774A1 Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions |
| 05/04/2006 | WO2006046735A1 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 05/04/2006 | WO2006046575A1 Amorphous object of cinnamide compound |
| 05/04/2006 | WO2006046552A1 Novel nitrogenous heterocyclic compounds and salts thereof |
| 05/04/2006 | WO2006046131A1 Tetralin histamine-3 receptor antagonists |
| 05/04/2006 | WO2006045478A1 New indole or benzimidazole derivatives |
| 05/04/2006 | WO2006045459A1 Thrombin inhibitors |
| 05/04/2006 | WO2006045416A1 Quinoline derivatives |
| 05/04/2006 | WO2006045204A1 Aryl sulfonic pyridoxines as antiplatelet agents |
| 05/04/2006 | WO2006045203A1 Substituted pyridoxines as anti-platelet agents |
| 05/04/2006 | WO2006036497A3 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 05/04/2006 | WO2006032994A3 Muscarinic receptor antagonists |
| 05/04/2006 | WO2006027628A3 Naphthalimide derivatives as antiviral agents |
| 05/04/2006 | WO2006023573A3 Aliphatic amide & ester pyrazinoylguanidine sodium channel blockers |
| 05/04/2006 | WO2006021454A3 Pyrimidine derivatives |
| 05/04/2006 | WO2005123718A3 Benzimidazolone carboxylic acid derivatives |
| 05/04/2006 | WO2005123692A8 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors |
| 05/04/2006 | WO2005112938A3 Disalt inhibitors of il-12 production |
| 05/04/2006 | WO2005109987A3 3-(((4-phenyl)-piperazine-1-yl)-alkyl)-3-alkyl-1, 3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders |
| 05/04/2006 | WO2005060665A8 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors |
| 05/04/2006 | WO2005049581A8 Pyridazin-3 (2h) -one derivatives and their use as pde4 inhibitors |
| 05/04/2006 | WO2005025681A3 A system for and a method of manufacturing personal golf putters |
| 05/04/2006 | US20060094879 5-{4-[1-(2-Ethoxyethyl)-1H-indol-3-yl]piperidin-1-ylmethyl}-2-methoxybenzoic acid; histamine H1 antagonists; bronchial dialtors; asthma; allergic rhinitis; conjunctivitis; dermatitis; urticaria; selective antiallergic effects so less side effect reduction and lower dosage |
| 05/04/2006 | US20060094878 Process for preparing substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds |
| 05/04/2006 | US20060094877 Process for preparation of benzylpiperidine compounds |
| 05/04/2006 | US20060094762 Magnesium salt of imidazole derivative |
| 05/04/2006 | US20060094761 such as 4-{4-fluoromethyl-2-methyl-5-[(4-carbamimidoyl-benzyloxy)-methyl]-pyridin-3-yloxymethyl}-benzamidine, that inhibit the proteases of the blood and thus block platelet aggregation, used for the treatment of cardiovascular disorders |
| 05/04/2006 | US20060094758 N-substituted piperidine derivatives as serotonin receptor agents |
| 05/04/2006 | US20060094757 Substantially pure cilostazol and processes for making same |
| 05/04/2006 | US20060094756 combining 6-hydroxy-3,4-dihydroquinolinone and an alkali metal carbonate; removing water using molecular sieves; adding 1-cyclohexyl-5-(4-halobutyl)-tetrazole; and recovering cilostazol. |
| 05/04/2006 | US20060094743 Isoquinoline compounds and medicinal use thereof |
| 05/04/2006 | US20060094735 Compounds for cell proliferation, anticancer agents, kinesin inbiitors |
| 05/04/2006 | US20060094732 Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 05/04/2006 | US20060094730 Water-soluble thalidomine derivatives |
| 05/04/2006 | US20060094727 Inhibitors of macrophase migration inhibitory factor and methods for identifying the same |